Hong-Xia Wang Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2005	Two-dimensional electrophoresis protein profiling as an analytical tool for human acute leukemia classification.
10/2004	Proteomic analysis of human acute leukemia cells: insight into their classification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong-Xia Wang Research Topics

Disease

19	Neoplasms (Cancer) 10/2018 - 06/2005
12	Inflammation (Inflammations) 01/2022 - 01/2013
11	Cardiomegaly (Heart Hypertrophy) 02/2024 - 08/2013
11	Hypertrophy 01/2022 - 03/2008
10	Fibrosis (Cirrhosis) 01/2020 - 10/2013
8	Breast Neoplasms (Breast Cancer) 02/2019 - 12/2010
7	Hypertension (High Blood Pressure) 01/2023 - 10/2011
6	Heart Diseases (Heart Disease) 12/2019 - 10/2013
6	Hepatocellular Carcinoma (Hepatoma) 12/2016 - 06/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2013
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2017 - 10/2004
4	Myocardial Infarction 06/2015 - 01/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 06/2014
3	Infarction (Infarctions) 03/2016 - 09/2014
3	Ischemia 01/2016 - 08/2005
3	Reperfusion Injury 04/2014 - 08/2005
2	Sepsis (Septicemia) 07/2023 - 01/2011
2	Vascular System Injuries 01/2023 - 03/2016
2	Atherosclerosis 01/2021 - 07/2019
2	Pathologic Complete Response 10/2018 - 03/2013
2	Carcinogenesis 09/2018 - 01/2018
2	Body Weight (Weight, Body) 01/2017 - 01/2013
2	Atrophy 02/2016 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2016 - 04/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2014 - 08/2005
2	AIDS-Related Complex (ARC) 08/2013 - 03/2008
2	Adenocarcinoma 03/2012 - 03/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2005 - 10/2004
2	Leukemia 01/2005 - 10/2004
1	Stroke (Strokes) 11/2023
1	Edema (Dropsy) 07/2023
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Pain (Aches) 07/2022
1	Hyperhidrosis 07/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 01/2020
1	Fatty Liver 01/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2004
12	Angiotensin IIIBA 02/2024 - 03/2008
7	CytokinesIBA 01/2018 - 06/2005
5	Peptides (Polypeptides)IBA 01/2023 - 06/2005
5	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 02/2015
5	CollagenIBA 01/2018 - 10/2011
4	LipidsIBA 11/2023 - 12/2011
4	Interleukin-6 (Interleukin 6)IBA 07/2023 - 06/2005
4	SaltsIBA 01/2023 - 01/2017
4	AutoantibodiesIBA 01/2023 - 09/2006
4	urotensin IIIBA 01/2021 - 01/2013
4	Small Interfering RNA (siRNA)IBA 08/2014 - 10/2011
3	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2024 - 12/2013
3	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2023 - 01/2017
3	Acetates (Acetic Acid Esters)FDA Link 01/2023 - 01/2017
3	UbiquitinIBA 01/2020 - 01/2016
3	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2019 - 01/2017
3	Messenger RNA (mRNA)IBA 10/2015 - 08/2013
2	LipopolysaccharidesIBA 07/2023 - 01/2013
2	EpitopesIBA 01/2023 - 06/2005
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2013
2	NF-kappa B (NF-kB)IBA 01/2020 - 01/2019
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2020 - 03/2008
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 10/2015
2	InterleukinsIBA 09/2018 - 06/2005
2	NucleotidesIBA 09/2018 - 03/2016
2	Polo-Like Kinase 1IBA 01/2018 - 08/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 08/2005
2	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 01/2016
2	ProdrugsIBA 04/2016 - 01/2016
2	LigandsIBA 03/2016 - 04/2015
2	p38 Mitogen-Activated Protein KinasesIBA 03/2016 - 12/2014
2	Ligases (Synthetase)IBA 01/2016 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 06/2015 - 03/2014
2	Caspase 3 (Caspase-3)IBA 04/2015 - 04/2014
2	baicaleinIBA 04/2015 - 04/2014
2	polyethylene glycol polyethyleneimine nanogelIBA 12/2013 - 11/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2013 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013 - 08/2013
2	Casein Kinase II (Casein Kinase 2)IBA 08/2013 - 03/2008
2	N- methylsulfonyl- 6- (2- propargyloxyphenyl)hexanamideIBA 11/2012 - 01/2011
2	11,12-epoxy-5,8,14-eicosatrienoic acidIBA 01/2011 - 08/2005
1	leonurineIBA 11/2023
1	Neutralizing AntibodiesIBA 07/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Peptide LibraryIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	VO-OHpicIBA 01/2020
1	UbiquinoneIBA 01/2020
1	FlavoproteinsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	TensinsIBA 01/2020
1	EnzymesIBA 01/2020

Therapy/Procedure

14	Therapeutics 07/2019 - 12/2010
9	Drug Therapy (Chemotherapy) 06/2017 - 06/2005
1	Intraperitoneal Injections 07/2023
1	Anesthesia 07/2022
1	Intravenous Anesthesia 07/2022
1	Sympathectomy (Sympathectomies) 07/2022